Novocuff Raises $26 Million to Reduce Preterm Births Using a Novel Technology nextdigitalhealth.com

Novocuff, Inc., a medical device technology company focused on improving pregnancy outcomes and minimizing the risk of preterm birth, has secured a $26 million series A funding round to fuel growth and support its pivotal clinical trials in the US.

The round was spearheaded by AXA IM Alts via its subsidiary, Global Healthcare Private Equity Strategy, supported by a significant investment from Laerdal Million Lives Fund.

https://nextdigitalhealth.com/funding-news/novocuff-raises-26-million-to-reduce-preterm-births-using-a-novel-technology/